Read More Analyst Ratings News Price Target Baird Maintains Outperform on Bath & Body Works, Lowers Price Target to $40 By Benzinga Newsdesk July 21, 10:27 AM Baird analyst Mark Altschwager maintains Bath & Body Works (NYSE:BBWI) with a Outperform and lowers the price target from $50 to $40. BBWI
Read More Analyst Color Analyst Ratings Equities General Markets News Price Target Reiteration Trading Ideas Papa John’s Reinvents With Service & Innovation: Analyst Highlights Brand’s Growth Trajectory By Shivani Kumaresan August 31, 1:21 PM Stephens analyst Joshua Long reiterated an PZZA
Read More Dividends Earnings News $1000 Invested In MercadoLibre 15 Years Ago Would Be Worth This Much Today By Benzinga Insights August 2, 1:01 PM MercadoLibre (NASDAQ:MELI) has outperformed the market over the past 15 years by 18.36% on an annualized basis producing an average annual return of 25.35%. Currently, MercadoLibre has a market capitalization of $42.57 billion. MELI
Read More Biotech General News bluebird bio Says List Price Of Newly-Approved Gene Therapy Is At $2.8M By Michael Horton August 17, 1:48 PM -Reuters BLUE